English 
Español 
What is Ozempic and Can it Help with Weight Loss?
Maintaining Healthy Blood Sugar Levels with Ozempic
Ozempic is a medication approved by the FDA to treat type 2 diabetes. It is also known as semaglutide and is a protein that naturally occurs in the intestines. Ozempic helps to maintain healthy blood sugar levels by stimulating the pancreas to secrete insulin in proportion to the amount of sugar in the blood. This reduces the risk of hypoglycemia, a condition where blood sugar levels drop too low.
Appetite Suppression and Weight Loss with Ozempic
Aside from helping to control blood sugar, Ozempic can also aid in weight loss. It works by activating appetite suppression pathways in the brain and slowing the rate at which food passes through the stomach. On average, diabetic patients on Ozempic can expect to lose about 10% of their body weight with 68 weeks of therapy.
Ozempic and Cardiovascular Risk Reduction
One of the benefits of insulin secretion in proportion to the amount of sugar in the blood is risk reduction of heart attack and stroke. By preventing drastic changes in blood sugar levels, Ozempic reduces the risk of heart attack and stroke in patients with type 2 diabetes and cardiovascular disease.
The Fine Line between Ozempic and Wegovy for Weight Loss
Now, you might be wondering if Ozempic is approved for weight loss. Well, technically it’s not, even though one of its major benefits is appetite suppression and subsequent weight loss. But here’s the catch: semaglutide, which is the generic name for Ozempic, is approved by the FDA for weight loss at a higher dosage.
When semaglutide is prescribed at a dose of 1 mg once weekly, it qualifies under the brand name Ozempic and is approved by the FDA for treatment of type 2 diabetes and prevention of major adverse cardiovascular events. When semaglutide is prescribed at a dose of 2.4 mg once weekly, it qualifies under the brand name Wegovy, which is approved by the FDA for weight loss, but not for management of type 2 diabetes.
Despite Ozempic not being officially approved by the FDA for weight loss, it does help patients with type 2 diabetes lose weight. In fact, patients taking Ozempic achieve an average weight loss of 9.6% after 68 weeks of therapy. In comparison, Wegovy, which is semaglutide prescribed at the greater dose, helps patients achieve an average weight loss of 14.9% over 68 weeks.
The Potential of Ozempic for Weight Loss and Managing Type 2 Diabete
In conclusion, Ozempic is an effective medication for treating type 2 diabetes, and it can also help with weight loss. Although it’s not officially approved by the FDA for weight loss, it has been found to be effective in clinical studies. If you’re interested in trying Ozempic for weight loss, talk to your doctor or our medical providers on Umedoc to see if it’s the right option for you.
Summary:
- Ozempic is a medication approved by the FDA for treating type 2 diabetes.
- It is a protein that naturally occurs in the intestines and has a wide range of actions in the body, including maintaining healthy blood sugar levels and suppressing appetite.
- By stimulating the pancreas to secrete insulin in proportion to the amount of sugar in the blood, Ozempic helps maintain a healthy blood sugar level without significant risk of lowering it too much.
- Ozempic also reduces the risk of heart attack and stroke in patients with type 2 diabetes and cardiovascular disease by preventing drastic changes in blood sugar levels.
- Ozempic is also an effective medication for weight loss, helping patients to reduce food cravings by activating appetite suppression pathways in the brain and slowing the rate at which food passes through the stomach.
- Semaglutide is the generic name for Ozempic, and it is also approved by the FDA for weight loss when prescribed at a dose of 2.4 mg once weekly under the brand name Wegovy.
- Despite not being FDA-approved for weight loss, Ozempic has been used off-label to help patients with type 2 diabetes lose weight, with an average weight loss of 9.6% after 68 weeks of therapy.
- Semaglutide at the greater dose (Wegovy) helps patients achieve an average weight loss of 14.9% over 68 weeks, as the amount of weight loss achieved with semaglutide is proportional to the amount of semaglutide prescribed.
This article reviewed by Dr. Jim Liu, MD and Ms. Deb Dooley, APRN.
There’s nothing more important than our good health – that’s our principal capital asset.
#medical #telehealth #umedoc
